Contraline is developing the first long-lasting, reversible contraceptive for men
Sign up today and learn more about Contraline Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Contraline Stock
Contraline is a biotechnology company developing a long-lasting, non-hormonal, and reversible male contraceptive.
Nicole E. Hastings
Co-Founder & CEO
Forbes - Nov, 14 2017The 2018 30 Under 30 In Healthcare
TechCrunch - Apr, 5 2017Meet the company that’s looking to make non-surgical male birth control a reality
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase